These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1682465)

  • 21. Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension.
    Fici F; Celik T; Balta S; Iyisoy A; Unlu M; Demitkol S; Yaman H; Brambilla G; Kardesoglu E; Kilic S; Yokusoglu M; Grassi G
    J Cardiovasc Pharmacol; 2013 Oct; 62(4):388-93. PubMed ID: 23921307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of nebivolol on adrenoceptors in the heart and in resistance arterioles in the rat. Quantitative intravital microscopic analysis.
    Loots W; De Clerck F
    Eur J Pharmacol; 1990 Apr; 179(1-2):177-86. PubMed ID: 1973102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereochemical comparison of nebivolol with other beta-blockers.
    Siebert CD; Hänsicke A; Nagel T
    Chirality; 2008 Feb; 20(2):103-9. PubMed ID: 18072266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
    Celik T; Iyisoy A; Kursaklioglu H; Kardesoglu E; Kilic S; Turhan H; Yilmaz MI; Ozcan O; Yaman H; Isik E; Fici F
    J Hypertens; 2006 Mar; 24(3):591-6. PubMed ID: 16467663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of nebivolol and metoprolol on inflammatory mediators in human coronary endothelial or smooth muscle cells. Effects on neointima formation after balloon denudation in carotid arteries of rats treated with nebivolol.
    Wolf SC; Sauter G; Preyer M; Poerner T; Kempf VA; Risler T; Brehm BR
    Cell Physiol Biochem; 2007; 19(1-4):129-36. PubMed ID: 17310107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and metabolic effects of cardioselective beta-adrenoblockers nebivolol and metoprolol in patients with hypertension and ischemic heart disease associated with type 2 diabetes].
    Makolkin VI; Akhmedova OO; Buval'tsev VI; Gavrilov IuV; Petriĭ VV
    Kardiologiia; 2003; 43(2):40-3. PubMed ID: 12891271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide mediated venodilator effects of nebivolol.
    Bowman AJ; Chen CP; Ford GA
    Br J Clin Pharmacol; 1994 Sep; 38(3):199-204. PubMed ID: 7826820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol.
    Stoleru L; Wijns W; van Eyll C; Bouvy T; Van Nueten L; Pouleur H
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):183-90. PubMed ID: 7692155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR; Marchione CS
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
    Brixius K; Bundkirchen A; Bölck B; Mehlhorn U; Schwinger RH
    Br J Pharmacol; 2001 Aug; 133(8):1330-8. PubMed ID: 11498519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.
    Agabiti Rosei E; Rizzoni D
    Drugs; 2007; 67(8):1097-107. PubMed ID: 17521213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human beta 1- and beta 2-adrenergic receptor binding and mediated accumulation of cAMP in transfected Chinese hamster ovary cells. Profile of nebivolol and known beta-adrenergic blockers.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1991 Oct; 42(9):1683-9. PubMed ID: 1681809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.
    Ceron CS; Rizzi E; Guimarães DA; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2013 Dec; 65():47-56. PubMed ID: 23806385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
    Bundkirchen A; Brixius K; Bölck B; Schwinger RH
    J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
    Hillebrand U; Lang D; Telgmann RG; Hagedorn C; Reuter S; Kliche K; Stock CM; Oberleithner H; Pavenstädt H; Büssemaker E; Hausberg M
    J Hypertens; 2009 Mar; 27(3):517-26. PubMed ID: 19330906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritis.
    Peters H; Rückert M; Gaedeke J; Liefeldt L; Ketteler M; Sharma AM; Neumayer HH
    J Hypertens; 2003 Apr; 21(4):771-80. PubMed ID: 12658024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major differences in gene expression in human coronary smooth muscle cells after nebivolol or metoprolol treatment.
    Wolf SC; Sauter G; Jobst J; Kempf VA; Risler T; Brehm BR
    Int J Cardiol; 2008 Mar; 125(1):4-10. PubMed ID: 17467819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nebivolol is devoid of intrinsic sympathomimetic activity.
    Janssens WJ; Van de Water A; Xhonneux R; Reneman RS; Van Nueten JM; Janssen PA
    Eur J Pharmacol; 1989 Jan; 159(1):89-95. PubMed ID: 2565239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension.
    Serg M; Kampus P; Kals J; Zagura M; Zilmer M; Zilmer K; Kullisaar T; Eha J
    Scand J Clin Lab Invest; 2012 Sep; 72(5):427-32. PubMed ID: 22708640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockers.
    Patel RS; Sharma KH; Kamath NA; Patel NH; Thakkar AM
    Indian J Pharmacol; 2014; 46(5):485-9. PubMed ID: 25298575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.